Clinical Trial Update: A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis [Phase 1, Phase 2]

View source ↗

Summary

This is a completed Phase 1/2 trial comparing AIN457 (secukinumab) to placebo in adults with moderate-to-severe stable plaque psoriasis. Results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Secukinumab (AIN457) (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Plaque Psoriasis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-04-10